Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Williams

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Hematological Oncology|May 26, 2023
Intravenous immunoglobulin prophylaxis is associated with decreased rate of infection-related hospitalizations in multiple myeloma patientsMichael Sheu, Sofia Molina Garcia, Meera Patel, et al.
Journal of the American Heart Association|July 4, 2019
Prognostically Significant Myocardial Injury in Patients Undergoing Transcatheter Aortic Valve ReplacementVikram Sharma, Tanujit Dey, Kesavan Sankaramangalam, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 6, 2023
Risk of Venous Thromboembolism in Multiple Myeloma Patients During the Immediate Peri-Autologous Hematopoietic Cell Transplantation PhaseHussein Awada, Adel Hajj Ali, Faiz Anwer, et al.
Journal of Clinical Medicine|April 13, 2024
Role of Palliative Care in the Supportive Management of AL Amyloidosis-A ReviewMuhammad Hamza Habib, Yun Kyoung Ryu Tiger, Danai Dima, et al.
Blood Reviews|May 17, 2025
Suppression to removal, an emerging therapeutic approach for AL amyloidosis: A comprehensive review with early human data and pharmacokinetics of CAEL-101 antibodyAnam Ashfaque, Yara Shatnawi, Shahzad Raza, et al.
Cancers|April 13, 2023
Management of Relapsed-Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical PracticeDanai Dima, Fauzia Ullah, Sandra Mazzoni, et al.
Journal of Cellular and Molecular Medicine|June 20, 2025
Signalling Network Analysis of Blood Mononuclear Cells From Clinical Samples by Bivariate CorrelationDavid Kaplan, Hillard M Lazarus, Jason Valent, et al.
Journal of Cellular and Molecular Medicine|September 22, 2025
Molecular Expression Differences in Specific Blood Mononuclear Cell-Types Identify Patients With AL AmyloidosisDavid Kaplan, Eric Christian, Jason Valent, et al.
Leukemia|February 3, 2022
Inflammation and infection in plasma cell disorders: how pathogens shape the fate of patientsJessica Caro, Marc Braunstein, Louis Williams, et al.
Cancers|May 27, 2026
Smoldering Multiple Myeloma: Early Intervention or Structured Surveillance? A Comprehensive Review of Evidence for and Against Early TherapyKirti Arora, Lara Soueid, Louis Williams, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Hematological Oncology|May 26, 2023
Intravenous immunoglobulin prophylaxis is associated with decreased rate of infection-related hospitalizations in multiple myeloma patientsMichael Sheu, Sofia Molina Garcia, Meera Patel, et al.
Journal of the American Heart Association|July 4, 2019
Prognostically Significant Myocardial Injury in Patients Undergoing Transcatheter Aortic Valve ReplacementVikram Sharma, Tanujit Dey, Kesavan Sankaramangalam, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 6, 2023
Risk of Venous Thromboembolism in Multiple Myeloma Patients During the Immediate Peri-Autologous Hematopoietic Cell Transplantation PhaseHussein Awada, Adel Hajj Ali, Faiz Anwer, et al.
Journal of Clinical Medicine|April 13, 2024
Role of Palliative Care in the Supportive Management of AL Amyloidosis-A ReviewMuhammad Hamza Habib, Yun Kyoung Ryu Tiger, Danai Dima, et al.
Blood Reviews|May 17, 2025
Suppression to removal, an emerging therapeutic approach for AL amyloidosis: A comprehensive review with early human data and pharmacokinetics of CAEL-101 antibodyAnam Ashfaque, Yara Shatnawi, Shahzad Raza, et al.
Cancers|April 13, 2023
Management of Relapsed-Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical PracticeDanai Dima, Fauzia Ullah, Sandra Mazzoni, et al.
Journal of Cellular and Molecular Medicine|June 20, 2025
Signalling Network Analysis of Blood Mononuclear Cells From Clinical Samples by Bivariate CorrelationDavid Kaplan, Hillard M Lazarus, Jason Valent, et al.
Journal of Cellular and Molecular Medicine|September 22, 2025
Molecular Expression Differences in Specific Blood Mononuclear Cell-Types Identify Patients With AL AmyloidosisDavid Kaplan, Eric Christian, Jason Valent, et al.
Leukemia|February 3, 2022
Inflammation and infection in plasma cell disorders: how pathogens shape the fate of patientsJessica Caro, Marc Braunstein, Louis Williams, et al.
Cancers|May 27, 2026
Smoldering Multiple Myeloma: Early Intervention or Structured Surveillance? A Comprehensive Review of Evidence for and Against Early TherapyKirti Arora, Lara Soueid, Louis Williams, et al.
Pageof 4